drugset
drugset / Trial / NCT03898024

Effects of SHR-1222 on Vascular Inflammatory Factors in Patients With Low Bone Mass

NCT03898024 ↗

Completed 50 enrolled Second Xiangya Hospital of Central South University
RandomizedParallel-groupQuadruple-blindTreatment

Summary

This study aims to investigate the effects of SHR-1222 on vascular inflammatory factors in patients with low bone mass.

Timeline

Start
2019-04-15
Primary completion
2020-07-27
Completion
2020-08-15

Drugs

EvaluationDrugModalityDoseRoute
Subject RESUGOSBART Monoclonal antibody — Subcutaneous

Indications

osteoporosis